Polaris Greystone Financial Group LLC bought a new position in shares of Cardinal Health Inc (NYSE:CAH) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 6,716 shares of the company’s stock, valued at approximately $363,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Ladenburg Thalmann Financial Services Inc. grew its position in Cardinal Health by 7.2% during the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 18,987 shares of the company’s stock worth $1,190,000 after buying an additional 1,272 shares in the last quarter. LPL Financial LLC grew its position in Cardinal Health by 18.2% during the first quarter. LPL Financial LLC now owns 30,719 shares of the company’s stock worth $1,925,000 after buying an additional 4,721 shares in the last quarter. Cubist Systematic Strategies LLC grew its position in Cardinal Health by 392.4% during the first quarter. Cubist Systematic Strategies LLC now owns 6,894 shares of the company’s stock worth $432,000 after buying an additional 5,494 shares in the last quarter. Atlantic Trust Group LLC grew its position in Cardinal Health by 13.6% during the first quarter. Atlantic Trust Group LLC now owns 60,815 shares of the company’s stock worth $3,812,000 after buying an additional 7,304 shares in the last quarter. Finally, Xact Kapitalforvaltning AB grew its position in Cardinal Health by 4.5% during the first quarter. Xact Kapitalforvaltning AB now owns 60,525 shares of the company’s stock worth $3,794,000 after buying an additional 2,592 shares in the last quarter. Institutional investors own 90.56% of the company’s stock.

Shares of CAH stock opened at $53.19 on Friday. The firm has a market capitalization of $15.95 billion, a price-to-earnings ratio of 10.64, a price-to-earnings-growth ratio of 1.68 and a beta of 1.02. Cardinal Health Inc has a fifty-two week low of $48.14 and a fifty-two week high of $75.75. The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.53 and a current ratio of 1.07.

Cardinal Health (NYSE:CAH) last issued its earnings results on Monday, August 6th. The company reported $1.01 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.93 by $0.08. Cardinal Health had a return on equity of 22.59% and a net margin of 0.19%. The firm had revenue of $35.35 billion for the quarter, compared to the consensus estimate of $34.38 billion. During the same quarter last year, the business posted $1.31 EPS. The company’s revenue was up 7.2% compared to the same quarter last year. On average, analysts forecast that Cardinal Health Inc will post 5.02 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, October 15th. Investors of record on Monday, October 1st were issued a dividend of $0.4763 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.48. The ex-dividend date was Friday, September 28th. This represents a $1.91 annualized dividend and a dividend yield of 3.58%. Cardinal Health’s dividend payout ratio (DPR) is 38.20%.

In related news, CEO Jon L. Giacomin sold 2,890 shares of the firm’s stock in a transaction on Monday, August 20th. The stock was sold at an average price of $51.95, for a total transaction of $150,135.50. Following the sale, the chief executive officer now owns 72,652 shares of the company’s stock, valued at approximately $3,774,271.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.10% of the company’s stock.

A number of equities research analysts have weighed in on CAH shares. Royal Bank of Canada set a $60.00 target price on Cardinal Health and gave the company a “hold” rating in a report on Friday, September 21st. Argus reduced their target price on Cardinal Health from $85.00 to $75.00 and set a “buy” rating on the stock in a report on Monday, July 16th. Morgan Stanley reduced their target price on Cardinal Health from $55.00 to $40.00 and set an “underweight” rating on the stock in a report on Tuesday, July 3rd. Mizuho reaffirmed a “hold” rating and issued a $53.00 target price on shares of Cardinal Health in a report on Sunday, August 12th. Finally, Robert W. Baird reaffirmed a “hold” rating and issued a $51.00 target price on shares of Cardinal Health in a report on Friday, July 20th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. Cardinal Health presently has an average rating of “Hold” and an average target price of $61.33.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Featured Story: Average Daily Trade Volume Explained

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.